# BridgeBio Pharma, Inc.: Form 4, filed Jul 3, 2019

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 4
- Filed: 2019-07-03
- Accepted by EDGAR: Jul 3, 2019, 16:30 ET
- Period: 2019-07-01
- Accession: 0000899243-19-019173
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000089924319019173/xslF345X03/doc4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000089924319019173/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000089924319019173/xslF345X03/doc4.xml

Filed Jul 3, 2019.
Source: SEC EDGAR, the filing index for accession 0000899243-19-019173. Last ingested by Listed: Oct 29, 2026, 19:20 ET. No prices; not investment advice.